Literature DB >> 12059039

Upregulation of neuronal nicotinic receptor subunits alpha4, beta2, and alpha7 in transgenic mice overexpressing human acetylcholinesterase.

Marie M Svedberg1, Anne-Lie Svensson, Mary Johnson, Mandy Lee, Osnat Cohen, Jennifer Court, Hermona Soreq, Elaine Perry, Agneta Nordberg.   

Abstract

Neuronal nicotinic receptor binding sites as well as mRNA levels encoding for subunits alpha4, beta2, and alpha7 were analysed in 3-mo-old transgenic mice generated with a neuronal overexpression of human acetylcholinesterase and in age-matched controls. The acetylcholinesterase transgenic mice display progressive cognitive impairment in spatial learning and memory. We here report a significantly increased [3H]epibatidine and [125I]alphabungarotoxin binding in the cortex and the caudate putamen of these mice. Quantitativein situ hybridization showed significant upregulation of mRNA corresponding to the nicotinic receptor subunits alpha4, beta2, and alpha7 in various brain regions in the transgenic mice compared to nontransgenic controls. Our results suggest that disruption of balanced cholinergic transmission by constitutive overexpression of acetylcholinesterase is accompanied by variable upregulation of several nicotinic receptor subtypes, in particular these associated with cholinergic terminals participating in compensatory response.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12059039     DOI: 10.1385/JMN:18:3:211

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  22 in total

1.  Muscarinic acetylcholine receptors activate expression of the EGR gene family of transcription factors.

Authors:  H von der Kammer; M Mayhaus; C Albrecht; J Enderich; M Wegner; R M Nitsch
Journal:  J Biol Chem       Date:  1998-06-05       Impact factor: 5.157

2.  Evidence that tobacco smoking increases the density of (-)-[3H]nicotine binding sites in human brain.

Authors:  M E Benwell; D J Balfour; J M Anderson
Journal:  J Neurochem       Date:  1988-04       Impact factor: 5.372

3.  Fundamental principles of in situ hybridization.

Authors:  J N Wilcox
Journal:  J Histochem Cytochem       Date:  1993-12       Impact factor: 2.479

4.  A transcription-activating polymorphism in the ACHE promoter associated with acute sensitivity to anti-acetylcholinesterases.

Authors:  M Shapira; I Tur-Kaspa; L Bosgraaf; N Livni; A D Grant; D Grisaru; M Korner; R P Ebstein; H Soreq
Journal:  Hum Mol Genet       Date:  2000-05-22       Impact factor: 6.150

5.  Muscular dystrophy alters the processing of light acetylcholinesterase but not butyrylcholinesterase forms in liver of Lama2(dy) mice.

Authors:  J L Gómez; M S García-Ayllón; F J Campoy; C J Vidal
Journal:  J Neurosci Res       Date:  2000-10-01       Impact factor: 4.164

6.  Effect of acute and subchronic nicotine treatment on cortical acetylcholine release and on nicotinic receptors in rats and guinea-pigs.

Authors:  A Nordberg; L Romanelli; A Sundwall; C Bianchi; L Beani
Journal:  Br J Pharmacol       Date:  1989-09       Impact factor: 8.739

7.  Tacrine interacts with an allosteric activator site on alpha 4 beta 2 nAChRs in M10 cells.

Authors:  A L Svensson; A Nordberg
Journal:  Neuroreport       Date:  1996-09-02       Impact factor: 1.837

8.  Acute stress facilitates long-lasting changes in cholinergic gene expression.

Authors:  D Kaufer; A Friedman; S Seidman; H Soreq
Journal:  Nature       Date:  1998-05-28       Impact factor: 49.962

9.  Nicotine-induced increase in neuronal nicotinic receptors results from a decrease in the rate of receptor turnover.

Authors:  X Peng; V Gerzanich; R Anand; P J Whiting; J Lindstrom
Journal:  Mol Pharmacol       Date:  1994-09       Impact factor: 4.436

10.  Transgenic expression of human acetylcholinesterase induces progressive cognitive deterioration in mice.

Authors:  R Beeri; C Andres; E Lev-Lehman; R Timberg; T Huberman; M Shani; H Soreq
Journal:  Curr Biol       Date:  1995-09-01       Impact factor: 10.834

View more
  5 in total

Review 1.  Cellular stress reactions as putative cholinergic links in Alzheimer's disease.

Authors:  Debra Toiber; Hermona Soreq
Journal:  Neurochem Res       Date:  2005 Jun-Jul       Impact factor: 3.996

2.  Changes in brain 11C-nicotine binding sites in patients with mild Alzheimer's disease following rivastigmine treatment as assessed by PET.

Authors:  Ahmadul Kadir; Taher Darreh-Shori; Ove Almkvist; Anders Wall; Bengt Långström; Agneta Nordberg
Journal:  Psychopharmacology (Berl)       Date:  2007-02-20       Impact factor: 4.530

3.  Impairment of reward-related learning by cholinergic cell ablation in the striatum.

Authors:  Yasuji Kitabatake; Takatoshi Hikida; Dai Watanabe; Ira Pastan; Shigetada Nakanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-11       Impact factor: 11.205

4.  CSF Cholinergic Index, a New Biomeasure of Treatment Effect in Patients With Alzheimer's Disease.

Authors:  Azadeh Karami; Maria Eriksdotter; Ahmadul Kadir; Ove Almkvist; Agneta Nordberg; Taher Darreh-Shori
Journal:  Front Mol Neurosci       Date:  2019-10-11       Impact factor: 5.639

5.  Upregulation of alpha7 Nicotinic Receptors by Acetylcholinesterase C-Terminal Peptides.

Authors:  Cherie E Bond; Martina Zimmermann; Susan A Greenfield
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.